You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Harvard Business School
McKinsey
Boehringer Ingelheim
Medtronic

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

Pharmacia Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Pharmacia
International Patents:264
US Patents:7
Tradenames:111
Ingredients:86
NDAs:136
Patent Litigation for Pharmacia: See patent lawsuits for Pharmacia

Drugs and US Patents for Pharmacia

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes   Start Trial   Start Trial
Pharmacia MAXAQUIN lomefloxacin hydrochloride TABLET;ORAL 020013-001 Feb 21, 1992 DISCN No No   Start Trial   Start Trial
Pharmacia And Upjohn FLORONE E diflorasone diacetate CREAM;TOPICAL 019259-001 Aug 28, 1985 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Pharmacia

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-002 Oct 31, 1988 3,755,427   Start Trial
Pharmacia And Upjohn HALCION triazolam TABLET;ORAL 017892-001 Nov 15, 1982 3,980,790   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 3,692,895   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for PHARMACIA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe 2007-07-30
➤ Subscribe Oral Suspension 100 mg/5 mL ➤ Subscribe 2009-08-03
➤ Subscribe Injection 2 mg/mL, 100 mL bag ➤ Subscribe 2009-12-29
➤ Subscribe Tablets 600 mg ➤ Subscribe 2005-12-21
➤ Subscribe Injection 2 mg/mL, 300 mL bag ➤ Subscribe 2009-09-01
➤ Subscribe Tablets 1 g ➤ Subscribe 2005-08-23

Supplementary Protection Certificates for Pharmacia Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0364417 9690031-1 Sweden   Start Trial PRODUCT NAME: LATANOPROST
1304992 2013/044 Ireland   Start Trial PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1353647 C300492 Netherlands   Start Trial PRODUCT NAME: AZTREONAM, NIET IN EEN SAMENSTELLING MET ARGININE, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN AZTREONAM, ANDERS DAN EEN ARGININEZOUT, IN HET BIJZONDER ALS AZTREONAMLYSINE; REGISTRATION NO/DATE: EU/1/09/543/001 20090921
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Harvard Business School
Merck
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.